CRISPR Therapeutics AG (CRSP) EBIT Margin Growth (3y) (2019 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) EBIT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1,354.00 |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -101,581.00 |
| Mar 31, 2026 | -886,885.00 |
| Dec 31, 2025 | 217.44 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 156,158.00 |
| Dec 31, 2024 | 94,857.00 |
| Sep 30, 2024 | -265,701.00 |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | -664,323.00 |
| Dec 31, 2023 | 2.92 Mn |
| Jun 30, 2023 | 18.32 Mn |
| Mar 31, 2023 | 4.68 Mn |
| Dec 31, 2022 | -219.24 Mn |
| Sep 30, 2022 | -19.41 Mn |
| Jun 30, 2022 | -9.87 Mn |
| Mar 31, 2022 | -395,732.00 |
| Dec 31, 2021 | 3.82 Mn |
| Sep 30, 2021 | -685,691.00 |
| Jun 30, 2021 | 351,169.00 |